| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 23.05.
| NASDAQ OMX Copenhagen A/S: Veloxis Pharmaceuticals A/S - reduction of the share capital by reduction of the nominal value per share | | 44 | GlobeNewswire |
| Veloxis Pharmaceuticals A/S - reduction of the share capital by reduction of
the nominal value per share
The share capital of the following share will be reduced on NASDAQ OMX
Copenhagen as per 29...
Mehr lesen zu:
NASDAQ OMX Copenhagen A/S: Veloxis Pharmaceuticals A/S - reduction of the share capital by reduction of the nominal value per share | |
| 23.05.
| Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro' and announces changes to management | | 22 | PR Newswire |
| HORSHOLM, Denmark, May 23, 2012 /PRNewswire/ --Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that it contemplates restructuring the company's operations in order to fully focus its resources...
Mehr lesen zu:
Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro' and announces changes to management | |
| 23.05.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro' and announces changes to management | | 38 | GlobeNewswire |
| Company Announcement no. 9/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, 23 May, 2012
Veloxis...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro' and announces changes to management | |
| 22.05.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S - Completion of the share capital reduction adopted at the ordinary general meeting on 18 April 2012 - updated articles of association. | | 22 | GlobeNewswire |
| Company Announcement no. 8/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, May 22, 2012
Veloxis Pharmaceuticals A/S - Completion...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S - Completion of the share capital reduction adopted at the ordinary general meeting on 18 April 2012 - updated articles of association. | |
| 15.05.
| Veloxis Pharmaceuticals announces financial results for the first quarter 2012 in line with expectations, Phase III activities for LCP-Tacro' progressing according to plan | | 34 | PR Newswire |
| HORSHOLM, Denmark, May 15, 2012 /PRNewswire/ --
Highlights:
Enrolment has been completed in the pivotal LCP-Tacro 3002 Phase III study in de novo kidney transplant patients....
Mehr lesen zu:
Veloxis Pharmaceuticals announces financial results for the first quarter 2012 in line with expectations, Phase III activities for LCP-Tacro' progressing according to plan | |
| 15.05.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals announces financial results for the first quarter 2012 in line with expectations, Phase III activities for LCP-Tacro' progressing according to plan | | 51 | GlobeNewswire |
| Company Announcement no. 7/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, 15 May, 2012
Veloxis Pharmaceuticals...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals announces financial results for the first quarter 2012 in line with expectations, Phase III activities for LCP-Tacro' progressing according to plan | |
| 09.05.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for 1st Quarter 2012 | | 32 | GlobeNewswire |
| Investor service announcement no. 1/2012
To: NASDAQ OMX Copenhagen Hoersholm, Denmark,
May 9, 2012
Veloxis Pharmaceuticals A/S to Host Conference Call Announcing...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for 1st Quarter 2012 | |
| 20.04.
| Veloxis Pharmaceuticals A/S: Articles of Association | | 42 | GlobeNewswire |
| Company Announcement no. 6/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, April 20,
2012
...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Articles of Association | |
| 18.04.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S - Passing of Ordinary General Meeting | | 49 | GlobeNewswire |
| Company Announcement no. 5/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, April 18,
2012...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S - Passing of Ordinary General Meeting | |
| 29.03.
| Veloxis Pharmaceuticals Completes Enrolment in LCP-Tacro' 3002 Pivotal Phase III Trial in Kidney Transplant | | 40 | PR Newswire |
| HORSHOLM, Denmark, March 29, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney...
Mehr lesen zu:
Veloxis Pharmaceuticals Completes Enrolment in LCP-Tacro' 3002 Pivotal Phase III Trial in Kidney Transplant | |
| 29.03.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals Completes Enrolment in LCP-Tacro' 3002 Pivotal Phase III Trial in Kidney Transplant | | 36 | GlobeNewswire |
| Company Announcement no. 4/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, 29 March, 2012
Veloxis...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals Completes Enrolment in LCP-Tacro' 3002 Pivotal Phase III Trial in Kidney Transplant | |
| 26.03.
| Veloxis Pharmaceuticals A/S: Notice to Convene Annual General Meeting | | 44 | GlobeNewswire |
| Company Announcement no. 3/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, 26 March, 2012
Notice to Convene Annual General...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Notice to Convene Annual General Meeting | |
| 07.03.
| Veloxis Pharmaceuticals Publishes Annual Report 2011 | | 37 | PR Newswire |
| HORSHOLM, Denmark, March 7, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) ('Veloxis') today published the annual report of Veloxis Pharmaceuticals A/S for the financial year 2011. The...
Mehr lesen zu:
Veloxis Pharmaceuticals Publishes Annual Report 2011 | |
| 07.03.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals publishes Annual Report 2011 | | 43 | GlobeNewswire |
| Company Announcement no. 3/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, 7 March 2012
Veloxis Pharmaceuticals A/S (OMX: VELO) ('Veloxis') today published the annual
report of Veloxis Pharmaceuticals...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals publishes Annual Report 2011 | |
| 01.03.
| Veloxis Pharmaceuticals A/S to Host Conference Call to Announce Annual Report 2011 | | 35 | PR Newswire |
| HORSHOLM, Denmark, March 1, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) will announce the Annual Report 2011 on Wednesday, March 7, 2012 after 1 pm CET. Veloxis' Management will host...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S to Host Conference Call to Announce Annual Report 2011 | |
| 01.03.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S to Host Conference Call to Announcing Annual Report 2011 | | 29 | GlobeNewswire |
| Investor service announcement no. 1/2012
To: NASDAQ OMX Copenhagen
Hoersholm, Denmark, March
1...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals A/S to Host Conference Call to Announcing Annual Report 2011 | |
| 29.02.
| Veloxis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference | | 20 | PR Newswire |
| HORSHOLM, Denmark, Feb. 29, 2012 /PRNewswire/ --Edward Koval, senior vice president, business development, of Veloxis Pharmaceuticals A/S, will present at the Cowen and Company 32nd Annual Health...
Mehr lesen zu:
Veloxis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference | |
| 09.02.
| Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference | | 14 | PR Newswire |
| HORSHOLM, Denmark, Feb. 9, 2012 /PRNewswire/ -- William J. Polvino M.D president and CEO of Veloxis Pharmaceuticals A/S, will present at the 14th Annual BIO CEO & Investor Conference...
Mehr lesen zu:
Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference | |
| 09.02.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference | | 44 | GlobeNewswire |
| Investor News
Hoersholm, Denmark, February 9, 2012
Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor
...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference | |
| 26.01.
| Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals Announces Financial Calendar for 2012 | | 36 | GlobeNewswire |
| Company Announcement no. 2/2012
To: NASDAQ OMX Copenhagen A/S
Hoersholm, Denmark, January 25, 2012
Veloxis...
Mehr lesen zu:
Veloxis Pharmaceuticals A/S: Veloxis Pharmaceuticals Announces Financial Calendar for 2012 | |
